FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791750786> ?p ?o ?g. }

• W2791750786 endingPage "6" @default.
• W2791750786 startingPage "1" @default.
• W2791750786 abstract "Purpose . To compare refractive and biometric outcomes in patients with type 1 retinopathy of prematurity (ROP) treated with intravitreal injection of ranibizumab (IVR) versus bevacizumab (IVB), at a corrected age of 3 years. Methods . A retrospective case series compared cycloplegic refractive statuses and biometric statuses in patients who received either IVR or IVB for type 1 ROP, from April 2011 to April 2014. Results . A total of 62 eyes (33 patients) with type 1 ROP were evaluated (26 eyes in 13 IVR patients and 36 eyes in 20 IVB patients). There were no differences in birth statuses including gestational age and birth body weight between the two groups. The prevalence of refractive error greater than 1 D was higher in the IVB group (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M1><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.03</mml:mn></mml:math>), and there was a higher prevalence of high myopia (<−5.0 D, <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M2><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.03</mml:mn></mml:math>) in the IVB group. Comparisons in biometric finding showed that IVB patients had shallower anterior chamber depth (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M3><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.01</mml:mn></mml:math>). Conclusion . Both IVR and IVB showed low refractive errors, even followed at the corrected age of 3 years. No difference was noted between the two groups in refractive statuses. However, IVB was associated with shallower anterior chamber and higher prevalence of refractive error at the corrected age of 3 years. This trial is registered with NCT03334513 ." @default.
• W2791750786 created "2018-03-29" @default.
• W2791750786 creator A5003610236 @default.
• W2791750786 creator A5004782890 @default.
• W2791750786 creator A5005138092 @default.
• W2791750786 creator A5041647347 @default.
• W2791750786 creator A5052180635 @default.
• W2791750786 creator A5079360325 @default.
• W2791750786 date "2018-01-01" @default.
• W2791750786 modified "2023-10-15" @default.
• W2791750786 title "Refractive and Biometric Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age" @default.
• W2791750786 cites W106587198 @default.
• W2791750786 cites W1531221131 @default.
• W2791750786 cites W1543694381 @default.
• W2791750786 cites W1603758502 @default.
• W2791750786 cites W1970399717 @default.
• W2791750786 cites W1971376343 @default.
• W2791750786 cites W2000576774 @default.
• W2791750786 cites W2024489457 @default.
• W2791750786 cites W2033615900 @default.
• W2791750786 cites W2048617928 @default.
• W2791750786 cites W2053866194 @default.
• W2791750786 cites W2062265875 @default.
• W2791750786 cites W2110201859 @default.
• W2791750786 cites W2113170046 @default.
• W2791750786 cites W2114405205 @default.
• W2791750786 cites W2138916632 @default.
• W2791750786 cites W2208869562 @default.
• W2791750786 cites W2334326681 @default.
• W2791750786 cites W2413795004 @default.
• W2791750786 cites W2490167875 @default.
• W2791750786 cites W2513481513 @default.
• W2791750786 cites W2565044909 @default.
• W2791750786 cites W2593221228 @default.
• W2791750786 cites W2766083475 @default.
• W2791750786 doi "https://doi.org/10.1155/2018/4565216" @default.
• W2791750786 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5866885" @default.
• W2791750786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29713524" @default.
• W2791750786 hasPublicationYear "2018" @default.
• W2791750786 type Work @default.
• W2791750786 sameAs 2791750786 @default.
• W2791750786 citedByCount "11" @default.
• W2791750786 countsByYear W27917507862019 @default.
• W2791750786 countsByYear W27917507862020 @default.
• W2791750786 countsByYear W27917507862021 @default.
• W2791750786 countsByYear W27917507862022 @default.
• W2791750786 countsByYear W27917507862023 @default.
• W2791750786 crossrefType "journal-article" @default.
• W2791750786 hasAuthorship W2791750786A5003610236 @default.
• W2791750786 hasAuthorship W2791750786A5004782890 @default.
• W2791750786 hasAuthorship W2791750786A5005138092 @default.
• W2791750786 hasAuthorship W2791750786A5041647347 @default.
• W2791750786 hasAuthorship W2791750786A5052180635 @default.
• W2791750786 hasAuthorship W2791750786A5079360325 @default.
• W2791750786 hasBestOaLocation W27917507861 @default.
• W2791750786 hasConcept C11413529 @default.
• W2791750786 hasConcept C118487528 @default.
• W2791750786 hasConcept C126322002 @default.
• W2791750786 hasConcept C154945302 @default.
• W2791750786 hasConcept C184297639 @default.
• W2791750786 hasConcept C2776694085 @default.
• W2791750786 hasConcept C2777802072 @default.
• W2791750786 hasConcept C2778257484 @default.
• W2791750786 hasConcept C2778376644 @default.
• W2791750786 hasConcept C2779234561 @default.
• W2791750786 hasConcept C2779918416 @default.
• W2791750786 hasConcept C2781100027 @default.
• W2791750786 hasConcept C2781135284 @default.
• W2791750786 hasConcept C2989513435 @default.
• W2791750786 hasConcept C33923547 @default.
• W2791750786 hasConcept C41008148 @default.
• W2791750786 hasConcept C54355233 @default.
• W2791750786 hasConcept C71924100 @default.
• W2791750786 hasConcept C86803240 @default.
• W2791750786 hasConceptScore W2791750786C11413529 @default.
• W2791750786 hasConceptScore W2791750786C118487528 @default.
• W2791750786 hasConceptScore W2791750786C126322002 @default.
• W2791750786 hasConceptScore W2791750786C154945302 @default.
• W2791750786 hasConceptScore W2791750786C184297639 @default.
• W2791750786 hasConceptScore W2791750786C2776694085 @default.
• W2791750786 hasConceptScore W2791750786C2777802072 @default.
• W2791750786 hasConceptScore W2791750786C2778257484 @default.
• W2791750786 hasConceptScore W2791750786C2778376644 @default.
• W2791750786 hasConceptScore W2791750786C2779234561 @default.
• W2791750786 hasConceptScore W2791750786C2779918416 @default.
• W2791750786 hasConceptScore W2791750786C2781100027 @default.
• W2791750786 hasConceptScore W2791750786C2781135284 @default.
• W2791750786 hasConceptScore W2791750786C2989513435 @default.
• W2791750786 hasConceptScore W2791750786C33923547 @default.
• W2791750786 hasConceptScore W2791750786C41008148 @default.
• W2791750786 hasConceptScore W2791750786C54355233 @default.
• W2791750786 hasConceptScore W2791750786C71924100 @default.
• W2791750786 hasConceptScore W2791750786C86803240 @default.
• W2791750786 hasLocation W27917507861 @default.
• W2791750786 hasLocation W27917507862 @default.
• W2791750786 hasLocation W27917507863 @default.
• W2791750786 hasLocation W27917507864 @default.
• W2791750786 hasLocation W27917507865 @default.

• next